Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock 70 kDa protein 4 (HSPA4), also known as APG-2, is a molecular chaperone belonging to the Hsp110/Hsp70 family (UniProt P34932). It plays a vital role in cellular proteostasis by assisting in protein folding, preventing aggregation, and facilitating the degradation of misfolded proteins (NCBI Gene 3308). In various cancers, such as colorectal cancer and leukemia, HSPA4 is frequently overexpressed and acts as a survival factor by stabilizing oncogenic client proteins and inhibiting apoptosis (PMID: 31435447). Targeting HSPA4 mRNA through RNA interference (RNAi) or antisense oligonucleotides (ASOs) aims to reduce the levels of this chaperone, thereby sensitizing tumor cells to stress and chemotherapy (PMID: 28656233). While specific clinical inhibitors for HSPA4 are currently in the experimental stage, it remains a significant target for therapeutic intervention and a potential biomarker for disease progression and prognosis. The molecule's involvement in the inflammatory response and its role as a co-chaperone further highlight its importance in maintaining cellular integrity under pathological conditions. Therapeutic challenges include the high sequence homology among Hsp70 family members, which complicates the development of isoform-specific inhibitors. Despite these challenges, HSPA4 remains a promising candidate for precision medicine in oncology.
RNA interference (RNAi) or antisense-mediated degradation of HSPA4 mRNA to prevent protein translation, or direct inhibition of the HSPA4 protein's ATPase activity to disrupt chaperone function.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock 70 kDa protein 4 (HSPA4) (HSPA4).